Autologous olfactory mucosal cell transplants in clinical spinal cord injury: A randomized double-blinded trial in a canine translational model

Brain

Volumn 135, Issue 11, 2012, Pages 3227-3237

  Granger, Nicolas ^a   Blamires, Helen ^a   Franklin, Robin J M ^a,b   Jeffery, Nick D ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

models; spinal cord injury; spinal cord injury repair; spinal cord plasticity

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOLOGOUS OLFACTORY MUCOSAL CELL TRANSPLANTATION; CELL TRANSPLANTATION; CELL TRANSPORT; CONTROLLED STUDY; DISEASE SEVERITY; DOG; FEMALE; GRAFT RECIPIENT; LOCOMOTION; MALE; MUCOSA CELL; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SPINAL CORD INJURY; THORACOLUMBAR SPINAL CORD INJURY; TREATMENT OUTCOME;

EID: 84870209043     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws268     Document Type: Article

References (46)

1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. Standardisation Sub-Committee of the International Continence Society. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003; 61: 37-49.
2. Anderson KD. Targeting recovery: priorities of the spinal cord-injured population. J Neurotrauma 2004; 21: 1371-83.
3. Arnold SA, Hagg T. Anti-inflammatory treatments during the chronic phase of spinal cord injury improve locomotor function in adult mice. J Neurotrauma 2011; 28: 1995-2002.
4. Barnett SC, Riddell JS. Olfactory ensheathing cell transplantation as a strategy for spinal cord repair -what can it achieve? Nat Clin Pract Neurol 2007; 3: 152-61.
5. Begley CG, Ellis LM. Drug development: raise standards for preclinical cancer research. Nature 2012; 483: 531-3.
6. Biering-Sørensen F, Craggs M, Kennelly M, Schick E, Wyndaele JJ. International urodynamic basic spinal cord injury data set. Spinal Cord 2008; 46: 513-6. (Pubitemid 351948244)
7. Chhabra HS, Lima C, Sachdeva S, Mittal A, Nigam V, Chaturvedi D, et al. Autologous mucosal transplant in chronic spinal cord injury: an Indian Pilot Study. Spinal Cord 2009; 47: 887-95.
8. Chiu SC, Hung HS, Lin SZ, Chiang E, Liu DD. Therapeutic potential of olfactory ensheathing cells in neurodegenerative diseases. J Mol Med (Berl) 2009; 87: 1179-89.
9. Chuah MI, Hale DM, West AK. Interaction of olfactory ensheathing cells with other cell types in vitro and after transplantation: glial scars and inflammation. Exp Neurol 2011; 229: 46-53.
10. Consort statement: http://www.consort-statement.org/consort-statement/ (June 2012, date last accessed).
11. da Costa RC, Poma R, Parent JM, Partlow G, Monteith G. Correlation of motor evoked potentials with magnetic resonance imaging and neurologic findings in Doberman Pinschers with and without signs of cervical spondylomyelopathy. Am J Vet Res 2006; 67: 1613-20.
12. Edgerton VR, Courtine G, Gerasimenko YP, Lavrov I, Ichiyama RM, Fong AJ, et al. Training locomotor networks. Brain Res Rev 2008; 57: 241-54.
13. Fawcett JW, Curt A, Steeves JD, Coleman WP, Tuszynski MH, Lammertse D, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 2007; 45: 190-205.
14. Fluehmann G, Doherr MG, Jaggy A. Canine neurological diseases in a referral hospital population between 1989 and 2000 in Switzerland. J Small Anim Pract 2006; 47: 582-7.
15. Franklin RJM, Gilson JM, Franceschini IA, Barnett SC. Schwann cell-like myelination following transplantation of an olfactory bulb-ensheathing cell line into areas of demyelination in the adult CNS. Glia 1996; 17: 217-24.
16. Galpern WR, Corrigan-Curay J, Lang AE, Kahn J, Tagle D, Barker RA, et al. Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: scientific and ethical considerations. Lancet Neurol 2012; 11: 643-50.
17. Hamilton L, Franklin RJM, Jeffery ND. Development of a universal measure of quadrupedal forelimb-hindlimb coordination using digital motion capture and computerised analysis. BMC Neurosci 2007; 8: 77.
18. Hamilton L, Franklin RJM, Jeffery ND. Quantification of deficits in lateral paw positioning after spinal cord injury in dogs. BMC Vet Res 2008; 4: 47.
19. Handa Y, Naito A, Watanabe S, Komatsu S, Shimizu Y. Functional recovery of locomotive behavior in the adult spinal dog. Tohoku J Exp Med 1986; 148: 373-84.
20. Ibrahim A, Li Y, Li D, Raisman G, El Masry WS. Olfactory ensheathing cells: ripples of an incoming tide? Lancet Neurol 2006; 5: 453-7.
21. Ito D, Fujita N, Ibanez C, Sasaki N, Franklin RJM, Jeffery ND. Serum-free medium provides a clinically relevant method to increase olfactory ensheathing cell numbers in olfactory mucosa cell culture. Cell Transplant 2008; 16: 1021-7. (Pubitemid 351732844)
22. Jeffery ND, Hamilton L, Granger N. Designing clinical trials in canine spinal cord injury as a model to translate successful laboratory interventions into clinical practice. Vet Rec 2011; 168: 102-7.
23. Jeffery ND, Lakatos A, Franklin RJ. Autologous olfactory glial cell transplantation is reliable and safe in naturally occurring canine spinal cord injury. J Neurotrauma 2005; 22: 1282-93.
24. Kadoya K, Tsukada S, Lu P, Coppola G, Geschwind D, Filbin MT, et al. Combined intrinsic and extrinsic neuronal mechanisms facilitate bridging axonal regeneration one year after spinal cord injury. Neuron 2009; 64: 165-72.
25. Kwon BK, Okon E, Hillyer J, Mann C, Baptiste D, Weaver LC, et al. A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury. J Neurotrauma 2011a; 28: 1545-88.
26. Kwon BK, Okon EB, Plunet W, Baptiste D, Fouad K, Hillyer J, et al. A systematic review of directly applied biologic therapies for acute spinal cord injury. J Neurotrauma 2011b; 28: 1589-610.
27. Li Y, Field PM, Raisman G. Regeneration of adult rat corticospinal axons induced by transplanted olfactory ensheathing cells. J Neurosci 1998; 18: 10514-24.
28. Lima C, Pratas-Vital J, Escada P, Hasse-Ferreira A, Capucho C, Peduzzi JD. Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study. J Spinal Cord Med 2006; 29: 191-203.
29. Lima C, Escada P, Pratas-Vital J, Branco C, Arcangeli CA, Lazzeri G, et al. Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury. Neurorehabil Neural Repair 2010; 24: 10-22.
30. Lowenstein PR, Castro MG. Uncertainty in the translation of preclinical experiments to clinical trials. Why do most Phase III trials fail? Curr Gene Ther 2009; 9: 368-374.
31. Mackay-Sim A, Fé ron F, Cochrane J, Bassingthwaighte L, Bayliss C, Davies W, et al. Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain 2008; 131: 2376-86.
32. National Spinal Cord Injury Center. https://www.nscisc.uab.edu/ PublicDocuments/nscisc-home/pdf/Facts%202011%20Feb%20Final. pdf (March 2012, date last accessed).
33. Olby N, Levine J, Harris T, Munana K, Skeen T, Sharp N. Long-Term functional outcome of dogs with severe injuries of the thoracolumbar spinal cord: 87 cases (1996-2001). J Am Vet Med Assoc 2003; 222: 762-9. (Pubitemid 36337313)
34. Poncelet L, Michaux C, Balligand M. Somatosensory potentials in dogs with naturally acquired thoracolumbar spinal cord disease. Am J Vet Res 1993; 54: 1935-41.
35. Priester WA. Canine intervertebral disc disease -occurrence by age, breed, and sex among 8117 cases. Theriogenology 1976; 6: 293-303.
36. Raisman G, Li Y. Repair of neural pathways by olfactory ensheathing cells. Nat Rev Neurosci 2007; 8: 312-9. (Pubitemid 46452322)
37. Ramó n-Cueto A, Cordero MI, Santos-Benito FF, Avila J. Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron 2000; 25: 425-35.
38. Ramó n-Cueto A, Munoz-Quiles C. Clinical application of adult olfactory bulb ensheathing glia for nervous system repair. Exp Neurol 2011; 229: 181-94.
39. Sasaki M, Lankford KL, Radtke C, Honmou O, Kocsis JD. Remyelination after olfactory ensheathing cell transplantation into diverse demyelinating environments. Exp Neurol 2011; 229: 88-98.
40. Skinner AP, Pachnicke S, Lakatos A, Franklin RJ, Jeffery ND. Nasal and frontal sinus mucosa of the adult dog contain numerous olfactory sensory neurons and ensheathing glia. Res Vet Sci 2005; 78: 9-15. (Pubitemid 39406726)
41. Sylvestre AM, Cockshutt JR, Parent JM, Brooke JD, Holmberg DL, Partlow GD. Magnetic motor evoked potentials for assessing spinal cord integrity in dogs with intervertebral disc disease. Vet Surg 1993; 22: 5-10.
42. Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, Hill CE, Sparling JS, Plemel JR, et al. A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma 2011; 28: 1611-82.
43. Thuret S, Moon LD, Gage FH. Therapeutic interventions after spinal cord injury. Nat Rev Neurosci 2006; 7: 628-43.
44. Wang D, Ichiyama RM, Zhao R, Andrews MR, Fawcett JW. Chondroitinase combined with rehabilitation promotes recovery of forelimb function in rats with chronic spinal cord injury. J Neurosci 2011; 31: 9332-44.
45. Wyrwich KW, Wolinsky FD. Identifying meaningful intra-individual change standards for health-related quality of life measures. J Eval Clin Pract 2000; 6: 39-49.
46. Yamamoto M, Raisman G, Li D, Li Y. Transplanted olfactory mucosal cells restore paw reaching function without regeneration of severed corticospinal tract fibres across the lesion. Brain Res 2009; 1303: 26-31.